Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    COVID-19 Affects Cancer Caregivers, but Here Are Ways to Support Them
    COVID-19
    COVID-19 Affects Cancer Caregivers, but Here Are Ways to Support Them
    February 19, 2021
    Celebrate Oncology Nurse Leaders During Black History Month
    ONS Leadership
    Celebrate Oncology Nurse Leaders During Black History Month
    February 03, 2021
    Am I Too Shy to Lead?
    Nurse staffing
    Am I Too Shy to Lead?
    January 29, 2021
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    nursing professional development
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    January 22, 2021
    The Case of Concurrent Therapy Concerns
    Treatment side effects
    The Case of Concurrent Therapy Concerns
    December 18, 2020
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Access to cancer care

    CMS Changes to Medicare Prescription Coverage Could Affect Patient Care
    Access to cancer care

    CMS Changes to Medicare Prescription Coverage Could Affect Patient Care

    From Teddy Roosevelt to JFK, presidents throughout history have sent legislation to Capitol Hill with the intent to expand healthcare coverage to more Americans. Finally, when Lyndon B. Johnson drafted a bill and pushed it through Congress by expanding sections of the Social Security Act, Medicare become an entitlement and is now implemented by the Centers for Medicare and Medicaid Services (CMS). During the past 50 years, federal health coverage has grown to include Medicaid, maternal and childcare assistance, public health programs, and prescription medication pricing.

    February 18, 2021
    How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials
    Cancer research

    How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials

    To improve clinical trial availability, effectiveness, and diversity in the era of the COVID-19 coronavirus, National Cancer Institute (NCI)-funded clinical trials should adjust their design to increase use of telemedicine and remote informed consent, among other strategies, several NCI department leaders wrote in a commentary in the Journal of the National Cancer Institute.

    January 06, 2021
    Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country
    Access to cancer care

    Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country

    When a patient comes to the doctor’s office with a generalized symptom such as an ongoing cough or chest heaviness, they are bound to have anxiety. In Wayne’s case, a patient with a lung mass that was identified unexpectedly, his anxiety was further compounded by feeling alone: his wife has dementia and his grown children live out of state. He also lives in a rural area and must drive a significant distance to get to a center for testing and diagnosis.

    December 04, 2020
    Older Adults Are Being Overscreened for Cancer
    Cancer screening

    Older Adults Are Being Overscreened for Cancer

    Many older adults are continuing cancer screenings beyond the recommended upper age limits, which range from age 65–75 years depending on the type of cancer screening, researchers reported in JAMA Network Open.

    November 25, 2020
    Research Shows That Telehealth Has the Power to Meet the Needs of Vulnerable Communities
    Research

    Research Shows That Telehealth Has the Power to Meet the Needs of Vulnerable Communities

    Telehealth resources have been present in the United States for several decades. Traditionally, clinicians used telehealth to help rural populations with limited access to care. However, telehealth innovations expand beyond home care coordination. We can use technology to reach even the most remote and vulnerable patients.  

    November 11, 2020
    Technology in Cancer Care
    Clinical practice

    Technology in Cancer Care

    Technology is synonymous with modern-day health care, and the experiences of 2020 have shown that telehealth allows clinicians to provide care along every inch of the cancer continuum. Although we’ve seen it used most recently to provide continuity of care from the safety of patients’ homes, one of telehealth's bigger purposes is overcoming geographic and practical disparities to enable more patients to access quality cancer care.

    November 03, 2020
    FCC and USDA Partner for Rural Telehealth Initiative
    Cancer health disparities

    FCC and USDA Partner for Rural Telehealth Initiative

    Rural Americans are more likely to have a fatal cancer diagnosis and face additional concerns like fewer hospitals and physicians in a “one-size-fits-all” healthcare system. To address the disparities, the Federal Communications Commission (FCC) partnered with the U.S. Department of Agriculture (USDA) to form the Rural Telehealth Initiative.

    September 22, 2020
    ONS Bridge

    Mylan Patient Specialists Help Support Patients Through Biosimilar Cancer Treatments

    Mylan understands that you care about your patients and that this may be a difficult time for them. Now more than ever, additional treatment options, such as biosimilars offerings may play an important role in providing patients access to medications they need.    

    September 08, 2020
    ONS Bridge

    Nurses Present Patient-Centered Research on Survivorship and Health Disparities

    Distress, uncertainty, and barriers to care are common experiences for patients with cancer and survivors. Yingzi Zhang, PhD, RN, of the School of Nursing at the University of Rochester in New York, and Jin Young Seo, PhD, WHNP-BC, RN, of Hunter College in New York, NY, reported on their research on quality of life and access to care in vulnerable patient populations.

    September 08, 2020
    U.S. Cancer Costs Projected to Increase to $245 Billion by 2030
    Access to cancer care

    U.S. Cancer Costs Projected to Increase to $245 Billion by 2030

    From 2015 to 2030, the costs associated with cancer will rise to $245 billion, researchers said in a report that was published in Cancer Epidemiology, Biomarkers, and Prevention.

    June 26, 2020
    Innovative Clinics Help Patients Safely Access Cancer Care During COVID-19
    COVID-19

    Innovative Clinics Help Patients Safely Access Cancer Care During COVID-19

    No longer just a convenience, drive-throughs are an essential part of social distancing during the COVID-19 coronavirus pandemic. Retailers and healthcare providers alike have taken it beyond the typical food, prescriptions, and banking, offering everything from merchandise to virus testing—and now, thanks to the innovation of two oncology nurses, cancer care.

    May 20, 2020
    Nurses Address Barriers to Care Through CoC’s Revised Standards
    Cancer health disparities

    Nurses Address Barriers to Care Through CoC’s Revised Standards

    Many factors can affect the way patients access their care. But one thing is certain: if patients don’t get the care they need, their chances for success decline. To address barriers to cancer care, the American College of Surgeons’ Commission on Cancer (CoC) outlined specific, measurable actions that institutions must take.

    May 07, 2020
    Patients Struggle to Access BMT During COVID-19
    COVID-19

    Patients Struggle to Access BMT During COVID-19

    Cancer does not stop progressing because of a pandemic. Although the COVID-19 coronavirus does not recognize that someone with leukemia has been fighting for months, even years, for remission to receive a lifesaving blood and marrow transplantation (BMT), a new program is ensuring that marrow products are available when patients need them. 

    April 24, 2020
    Medicare Cancer Screening; ACA Remains Strong; Medicare for All Cost
    Affordable Care Act (ACA)

    Advanced Cancer Screening Coverage; ACA Remains Strong; Medicare for All Cost

    Precision medicine has a been a hot topic in health care for years now, but costs and coverage issues have created challenges to get patients the genetic testing they need at an affordable cost. In a memo from October 29, 2019, the Centers for Medicare and Medicaid Services (CMS) proposed extending Medicare coverage to pay for genetic sequencing tests for certain hereditary types of ovarian and breast cancer.

    November 04, 2019
    HHS Secretary Azar Addresses American Cancer Society on Healthcare Delivery System
    Health Policy

    HHS Secretary Azar Addresses American Cancer Society on Healthcare Delivery System

    Reaching a broad audience, Department of Health and Human Services (HHS) Secretary Alex Azar spoke to the American Cancer Society’s Cancer Action Network in early September 2019 about the state of healthcare delivery in the United States and outlined the Trump administration’s priorities. Azar praised advocates for being leaders in promoting more investments for education, prevention, and research, and he noted the laudable achievements thus far.

    October 14, 2019
    FDA Calls Out Juul; Opioid Crackdown; States Tackle Drug Pricing
    U.S. Food and Drug Administration (FDA)

    FDA Calls Out Juul; Opioid Crackdown; States Tackle Drug Pricing

    With more deaths reported from vaping and a forceful U.S. Senate declaration to the U.S. Food and Drug Administration (FDA) acting commissioner to either enact stronger federal provisions restricting e-cigarettes, flavored tobacco, and inhalants or resign, the Trump administration moved quickly to demonstrate a recognition that cessation is a national, bipartisan concern. FDA sent a warning letter to Juul about its marketing and labeling, and the president, Health and Human Services secretary, and FDA commissioner issued very public statements on the matter, making it clear that federal oversight will be enforced on youth tobacco issues.

    September 16, 2019
    Access to Care and Nondiscrimination Are Two Key Ways to Address Cancer Disparities, According to ONS and ANA Position Statements
    Cancer health disparities

    Access to Care and Nondiscrimination Are Two Key Ways to Address Cancer Disparities, According to ONS and ANA Position Statements

    Cancer knows no race, color, nationality, or ethnicity. But although any person may one day develop cancer, incidence and mortality rates for some cancers are disproportionately higher in certain racial, ethnic, geographic, or socioeconomic groups. Here are just a few of the many identified cancer disparities, according to the National Cancer Institute.

    June 27, 2019
    Durbin Calls Out FDA; Medicare for All Support; Cancer Mortality Drops
    U.S. Food and Drug Administration (FDA)

    Durbin Calls Out FDA; Medicare for All Support; Cancer Mortality Drops

    In a letter to the U.S. Food and Drug Administration (FDA), Senator Dick Durbin (D-IL) shared harsh criticism for the agency’s lack of attention to the youth smoking epidemic. His letter from May 29, 2019, detailed efforts that the agency could be taking to curb the rise in youth tobacco use. The smoking cessation community, of which ONS is a palpable member, has sided with Durbin on the importance of continued FDA oversight on e-cigarettes and the vaping industry’s kid-friendly, fun-flavored tobacco products. Groups like the Campaign for Tobacco Free Kids have been forceful in comments to the agency about the need for stricter regulations on products.

    June 03, 2019
    CMS’s Final Medicare Part D Ruling Preserves Patient Access to Certain Cancer Drugs
    Prescription medication

    CMS’s Final Medicare Part D Ruling Preserves Patient Access to Certain Cancer Drugs

    Medicare Part D will continue to give patients access to certain cancer drugs, according Centers for Medicare and Medicaid Services’ (CMS’s) final ruling issued May 16, 2019. The final rule does not allow for utilization controls like step therapy and prior authorizations for patients who are already in an established treatment regimen; does not restrict drugs that have had certain price increases over a specified time period; and does not restrict new formulations of an existing protected class drug.

    May 21, 2019
    Oncology Urgent Care Clinics Are an Emerging Setting for Cancer Care Delivery
    Care coordination

    Oncology Urgent Care Clinics Are an Emerging Setting for Cancer Care Delivery

    Patients with cancer are living longer, embarking on complex treatment regimens, and experiencing more complications associated with care. As a result, a large volume of patients with cancer require urgent or emergency visits throughout their disease trajectory. Although the need remains constant, what has evolved over time are the chief complaints that bring patients in, the care associated with complications, and new options to lower the burden and cost of care.    

    April 15, 2019
    Opioid Access; Smoking Age Increase; House Medicare for All
    Prescription medication

    Opioid Access; Smoking Age Increase; House Medicare for All

    Efforts to curb the national opioid epidemic have taken shape in several ways, including redefined prescription guidelines. However, many insurers are now refusing to cover certain pain medications like the ones commonly prescribed to patients with cancer. For years, ONS has been meeting with congressional offices to advocate that access to prescription opioids for cancer survivors should be exempt from the strict limits assigned to other diagnoses. It’s always been a successful strategy, because ONS helps policy leaders understand that patients with cancer often struggle with issues related to severe pain management, quality of life, and end-of-life care.

    February 18, 2019
    Government Shutdown; ACA Ruled Invalid; Medicare for All Push
    Affordable Care Act (ACA)

    Government Shutdown; ACA Ruled Invalid; Medicare for All Push

    On January 3, 2019, the newly elected, Democrat-controlled House of Representatives introduced legislation to reopen the federal government and end the current shutdown. It’s not about the money, which is usually the case; it’s about the blame. The border wall funding—in whatever capacity—is politically driving the shutdown. But Senator Mitch McConnell (R-KY) doesn’t want to take up a Democrat-sponsored bill that he knows the president will veto. Democrats want that to happen to force the president to either accept the blame for the shutdown or to cave without funding for the wall and reopen the government.

    January 07, 2019
    Pre-Existing Conditions; Overcharging Prescription Drugs; Opposing Medicare for All
    Health Policy

    Pre-Existing Conditions; Overcharging Prescription Drugs; Opposing Medicare for All

    Although the Democrats have yet not formally taken control of the House of Representatives, many are primed and passionate about holding the Trump administration accountable after the November midterm elections. Through involvement in committees and as incoming chairs of powerful oversight panels, lawmakers are questioning officials about healthcare policy.

    December 17, 2018
    Medicare for All; New Congressional Priorities; Health Finance Committee
    Affordable Care Act (ACA)

    Medicare for All; New Congressional Priorities; Health Finance Committee

    With more than 70% of Americans supporting expanded Medicare, the single-payer Medicare for All rallying cry has gained significant support among progressives and moderates alike. A recent editorial report makes the case for its adoption with strong evidence from an economic point of view. During the November 2018 midterm election campaign, many incumbent Republicans—some of whom previously voted to repeal and replace the Affordable Care Act—now promised to uphold sections of the law, including protections for pre-existing conditions as their most important campaign commitment.

    December 03, 2018
    Dems on Health Care; Obamacare Enrollment; Pricey Precision Medicine
    Affordable Care Act (ACA)

    Dems on Health Care; Obamacare Enrollment; Pricey Precision Medicine

    To Rally Voters, Democrats Focus on Health Care as Their Closing Argument

    Although many states are already collecting early votes, Tuesday, November 6, 2018, will tell the full tale of the midterm elections. Many Democrats are emphasizing their focus on health care in the final days and hours before the election. By most measurable public opinion poll, health care remains the most important domestic issue for voters.

    November 05, 2018
    Lower Drug Prices; Democrat Dealmakers; Republicans Support Medicare Expansion
    Prescription medication

    Lower Drug Prices; Democrat Dealmakers; Republicans Support Medicare Expansion

    Fighting the cost of soaring prescription medications is a winning issue with tremendous bipartisan support. And reigning in exorbitant drug prices means patients will be the real winners. Recently, President Trump lauded his administration’s work to fight against high prescription drug costs, citing new efforts to reduce other countries from taking advantage of drug pricing.

    October 29, 2018
    Drug Pricing in Ads; Cancer Fertility Preservation; American Healthcare Panic
    Prescription medication

    Drug Pricing in Ads; Cancer Fertility Preservation; American Healthcare Panic

    Addressing the high cost of prescription medications has been an ongoing focus for the Trump administration. Its latest move, requiring drug companies to list their product’s market price on consumer ads, is an added level of transparency that didn’t exist before. Whether the decree will have an impact remains to be seen, but it may add some trust to the process.

    October 22, 2018
    CMS Administrator Shares Three Points to Bolster Medicaid
    Health Policy

    CMS Administrator Shares Three Points to Bolster Medicaid

    During a recent speech at the 2018 Medicaid Management Care Summit, Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma expressed a continued commitment to Medicaid’s legacy of supporting Americans in need.

    October 17, 2018
    Opioid Package Passes; Cheap Insurance Policies; Drug Patent Laws
    Prescription medication

    Opioid Package Passes; Cheap Insurance Policies; Drug Patent Laws

    For months, bipartisan lawmakers have worked together to build an opioid package aimed to tackle the nation’s abuse epidemic. After rounds of revisions and finally making it through both chambers of the House and Senate, the legislation is on its way to the president’s desk. The bill focuses funding efforts on addiction recovery programs and cracking down on the illegal medication trafficking.

    October 08, 2018
    Obamacare Premiums Stabilize; Senate Opioid Package; Medicare for All Questions
    Affordable Care Act (ACA)

    Obamacare Premiums Stabilize; Senate Opioid Package; Medicare for All Questions

    Millions of Americans depend on the Affordable Care Act (ACA) marketplace for their health insurance. In the past, costs have been unstable, seeing insurance premiums rise and competition flee. However, new reports estimate that Americans who receive health coverage from ACA will only see moderate increases to their premiums for 2019. During earlier repeal and replace efforts of Obamacare—otherwise known as ACA—the healthcare marketplace was volatile for consumers. Some insurers pulled out of the marketplace, leaving those that remained able to sharply increase premiums.

    September 17, 2018
    VA and NCI Collaborate on Access to Cancer Clinical Trials
    National Cancer Institute (NCI)

    VA and NCI Collaborate on Access to Cancer Clinical Trials

    A new cross-government program is underway to improve veterans’ access to clinical cancer trials. Together with the National Cancer Institute (NCI), the Department of Veterans Affairs (VA) Interagency Group to Accelerate Trials Enrollment launched in 12 VA facilities in summer 2018.

    September 12, 2018
    Trump Administration Forced to Help to ACA
    Affordable Care Act (ACA)

    Trump Administration Forced to Help to ACA; As Dems Campaign on Pre-Existing Conditions, Republicans Move In; Incidence of Pre-Existing Conditions Varies Across the United States

    Under the Affordable Care Act (ACA), each state has the right to create its own basic healthcare system within its own jurisdictions. Currently, only New York and Minnesota have made such systems available to residents who are just over the limit to qualify for Medicaid. Those individuals receive their health care from the state—until the Trump administration eliminated certain aspects of ACA that provided federal funding for these programs. After suing to overturn the administration’s ruling, the Department of Health and Human Services announced a settlement that would pay close to half a billion dollars to New York and Minnesota to support the affected plans.

    September 03, 2018
    If You Are Young and Have Cancer, Help Can Be Hard to Find
    Access to cancer care

    If You Are Young and Have Cancer, Help Can Be Hard to Find; Health Secretary Says Agency Has Power to Eliminate Drug Rebates; Trump Administration Needs to Step Up on Obamacare

    A cancer diagnosis at a young age can lead to serious hardship after completing treatments and moving into survivorship. Such was the case for Matthew Zachary after his cancer diagnosis at age 21. An interesting component to Zachary’s story—and that of many others like him—is that despite the higher number of insured Americans after the Affordable Care Act, costs and complications still plague patients. Access to health care can be a double-edge sword. It means more people are seeing providers, but it doesn't mean that people can afford those treatments.

    August 27, 2018
    House and Senate Pass the Childhood Cancer STAR Act
    Health Policy

    House and Senate Pass the Childhood Cancer STAR Act

    On May 22, the U.S. House of Representatives passed S.B. 292, the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act. The legislation will improve efforts to identify and track childhood cancer incidence, improve quality of life for childhood cancer survivors, ensure pediatric expertise at the National Institutes of Health by requiring the National Cancer Advisory Board to have at least one pediatric oncology expert on its board, and identify opportunities to increase childhood cancer research to better treat the 10,270 children diagnosed with cancer in the United States every year.   

    May 23, 2018
    World Cancer Day 2018
    Cancer prevention

    CDC Promotes World Cancer Day 2018

    On February 4, 2018, The Center for Disease Control and Prevention’s (CDC’s) annual World Cancer Day will aim to raise cancer awareness and support in a unified, global effort. The CDC’s efforts focus on cancer research and prevention, as well as improving services to patients with cancer, understanding and sharing common sentiments related to cancer, and mobilizing the global community against the disease.

    January 28, 2018
    House Passes CHIP Reauthorization Bill
    Access to cancer care

    House Passes CHIP Reauthorization Bill, Helps Insure Children With Cancer

    On November 3, 2017, the House of Representatives passed HR 3922, the Championing Healthy Kids Act, which reauthorizes the Children’s Health Insurance Program (CHIP) program for an additional five years. The act also reauthorizes public health programs. Previous funding for the CHIP program had expired September 30, 2017.

    November 07, 2017
    Capitol Hill Roundup
    Affordable Care Act (ACA)

    Former HHS Secretaries Urge Trump to Support ACA; Every U.S. County Will Have ACA Marketplace Option; Government May Look to Continuing Resolution to Prevent Shutdown

    The Affordable Care Act (ACA), better known as Obamacare, is likely here to stay. After previous attempts to repeal and replace the nation’s healthcare legislation, the Senate has finally moved on to other issues. However, this hasn’t stopped President Trump from attempting to undercut some of the financial components of the ACA. Recently, former Health and Human Services (HHS) secretaries from both the Democrats and Republicans urged Trump to support ACA subsidies that could affect the cost of more than 10 million American’s healthcare plans.

    August 28, 2017
    21st Century Cures
    Health Policy

    21st Century Cures Is a Broad Law That Impacts Narrow Categories

    “Congress is working together on a nonpartisan issue that will have a profound effect on the lives of all Americans. H.R. 6, the 21st Century Cures Act, will bring our health care innovation infrastructure into the 21st Century, delivering hope for patients and loved ones and providing necessary resources to researchers to continue their efforts to uncover the next generation of cures and treatments,” Chairman Fred Upton (R-MI) and Representative Diana DeGette (D-CO) discussed their vision for the 21st Century Cures initiative in April 2014.

    July 10, 2017
    Access to cancer care

    What Is ONS’s Stance on Handling Chemotherapy While Pregnant, Breastfeeding, or Trying to Conceive?

    One of the questions that ONS commonly receives in the clinical inbox (clinical@ons.org) is whether nurses who are pregnant, breastfeeding, or trying to conceive can safely administer or handle chemotherapy and other hazardous drugs.

    January 05, 2017
    Access to cancer care

    Improving Access to Care Is a Priority to the Cancer Moonshot

    In 1965, the monthly cost of cancer care was $100. By 2013, that number had risen to nearly $10,000. The skyrocketing cost of cancer drugs has, in part, played a major role in limiting access to care for patients with cancer. But money isn’t the only barrier: Location of treatment centers, lack of transportation, socioeconomic challenges, along with myriad cultural differences can play into the ways patients do—or don’t—access care.
    August 23, 2016
    Access to cancer care

    HHS Awards Health Centers Funding for Care Coordination

    In a move designed to improve the provision of health care, the Department of Health and Human Services (HHS) announced $8.8 million in awards to be given to community health centers across the United States. The goal is to increase patient-centered care and improve the quality of services for more Americans.
    August 18, 2016
    Access to cancer care

    Oncology Nurses Have Important Roles in Clinical Trial Access and Enrollment

    When President Obama announced the National Cancer Moonshot Initiative during his State of the Union address in January 2016, he set lofty goals for oncology professionals. One of those goals called for increased access to and participation in clinical trials. Clinical trial data are integral in getting cutting-edge treatments to market, where they can help improve cancer care. However, many patients aren’t fully educated about the efficacy of these new forms of treatment and what these trials entail.
    May 27, 2016
    Oncology nurses improve quality of patient care
    Access to cancer care

    IOM Report on Quality Cancer Care Has Implications for Oncology Nurses

    Since its pivotal report in 2001, the Institute of Medicine (IOM) has advocated for improving the quality of U.S. health care. To that effect, the IOM’s latest report outlines a systematic plan to help the U.S. healthcare system meet that goal.
    January 21, 2014
    Access to cancer care

    Cancer Insurance Checklist Helps Patients Navigate Choice of Insurance

    When the new state-based health insurance marketplaces open on October 1, 2013, as part of the Affordable Care Act, choice of insurance will be added to the long list of difficult decisions patients with cancer will face during their diagnosis and treatment.
    September 25, 2013
    HCT recipients and post-treatment care
    Access to cancer care

    Help Rural HCT Recipients Overcome Barriers to Post-Treatment Care

    For patients with hematologic malignancies and genetic immune disorders, HCT is a potentially curative treatment. However, because the therapy is so specialized, only select cancer centers with the appropriate expertise, resources, and experiences offer it.
    September 10, 2013
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    • Oncology nurse influence
    View All Topics
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲